Abstract
Background and Aims: Estrogens are important regulators of metabolic diseases including obesity and insulin resistance. The physiological and genomic signaling of estrogens is mainly mediated through the estrogen receptors (ER)α and ERβ. Although the role of ERβ in metabolism has recently gained attention, it is still unclear. However, no data report the different response to pharmaceutical activation of ERβ between sexes.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
